22 Stocks Moving In Tuesday's Pre-Market Session

Loading...
Loading...

Gainers

  • Moleculin Biotech Inc MBRX shares rose 40.7 percent to $3.39 in the pre-market trading session after the company disclosed that it has received the FDA approval for its Annamycin IND.
  • Ascena Retail Group Inc ASNA rose 16.6 percent to $2.53 in pre-market trading after the company posted stronger-than-expected results for its fourth quarter.
  • Chromadex Corp CDXC rose 16 percent to $5.00 in pre-market trading after the company reported top-line results from its second human clinical trial.
  • Greenhill & Co., Inc. GHL shares rose 13.9 percent to $16.40 in pre-market trading after the company disclosed outline of recap plan and share repurchase.
  • Social Reality Inc SRAX shares rose 10.2 percent to $2.70 in pre-market trading after surging 50.31 percent on Monday.
  • Vascular Biogenics Ltd VBLT rose 9.3 percent to $7.10 in pre-market trading after gaining 4.84 percent on Monday.
  • Apollo Endosurgery Inc APEN rose 7.7 percent to $4.90 in pre-market trading after falling 0.87 percent on Monday.
  • ProQR Therapeutics NV PRQR rose 7 percent to $6.90 in pre-market trading after the company disclosed 'positive' top-line data from Phase 1b study of QR-010.
  • Izea Inc IZEA rose 6.8 percent to $5.18 in pre-market trading after jumping 51.56 percent on Monday.
  • Akebia Therapeutics Inc AKBA rose 5.1 percent to $18.80 in pre-market trading. Akebia Therapeutics disclosed that statistically significant improvements in the primary endpoint were made in its Phase 2 study of Vadadustat.
  • Helios and Matheson Analytics Inc HMNY rose 4.6 percent to $8.68 in pre-market trading after surging 19.08 percent on Monday.
  • Red Hat Inc RHT rose 4.3 percent to $110.26 in pre-market trading after the company reported better-than-expected results for its second quarter and raised its guidance for the year.
  • Kitov Pharmaceuticals Holdings Ltd (ADR) KTOV shares rose 3.7 percent to $2.22 in pre-market trading after climbing 12.63 percent on Monday.


Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Losers

  • Axovant Sciences Ltd AXON shares fell 69.7 percent to $7.36 after the company disclosed that Phase 3 MINDSET clinical trial did not meet its co-primary efficacy endpoints.
  • Genocea Biosciences Inc GNCA fell 55.2 percent to $2.39 in pre-market trading after the company reported strategic shift to immuno-oncology and development of neoantigen cancer vaccines. The company also announced plans to explore strategic alternatives for GEN-003 and lower staff by 40 percent.
  • Kadmon Holdings Inc KDMN fell 21.1 percent to $2.99 in pre-market trading as the company reported mixed shelf offering.
  • QEP Resources Inc QEP shares fell 7.1 percent to $8.25 in pre-market trading after the company reported the closing of Pinedale asset sale and lowered its FY17 production outlook.
  • TherapeuticsMD Inc TXMD shares fell 6.8 percent to $5.65 in pre-market trading. TherapeuticsMD priced its 12.4 million share offering at $5.65 per share.
  • Sabra Health Care REIT Inc SBRA fell 6.1 percent to $20.98 in pre-market trading. Sabra Health Care REIT priced an underwritten public offering of 16,000,000 shares at $21.00 per share.
  • Aradigm Corporation ARDM shares fell 5.1 percent to $3.19 in pre-market trading after climbing 32.81 percent on Monday.
  • Cheesecake Factory Inc CAKE fell 4.6 percent to $39.70 in pre-market trading. Wedbush downgraded Cheesecake Factory from Outperform to Neutral.
  • Darden Restaurants, Inc. DRI shares fell 3.8 percent to $80.02 in pre-market trading. Darden posted in-line quarterly earnings.
Loading...
Loading...
Posted In: NewsMovers & ShakersPre-Market OutlookMarketsMovers#PreMarket GainersBiotechnologyHealth CareLosersTop Gainers
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...